| Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters KJ Cheung, V Padmanaban, V Silvestri, K Schipper, JD Cohen, ... Proceedings of the National Academy of Sciences 113 (7), E854-E863, 2016 | 709 | 2016 |
| Glycolysis is the primary bioenergetic pathway for cell motility and cytoskeletal remodeling in human prostate and breast cancer cells T Shiraishi, JE Verdone, J Huang, UD Kahlert, JR Hernandez, G Torga, ... Oncotarget 6 (1), 130, 2015 | 180 | 2015 |
| Technical challenges in the isolation and analysis of circulating tumor cells EE van der Toom, JE Verdone, MA Gorin, KJ Pienta Oncotarget 7 (38), 62754, 2016 | 104 | 2016 |
| Circulating tumour cells as biomarkers of prostate, bladder, and kidney cancer MA Gorin, JE Verdone, E Van Der Toom, TJ Bivalacqua, ME Allaf, ... Nature Reviews Urology 14 (2), 90-97, 2017 | 95 | 2017 |
| A phased strategy to differentiate human CD14+monocytes into classically and alternatively activated macrophages and dendritic cells JC Zarif, JR Hernandez, JE Verdone, SP Campbell, CG Drake, KJ Pienta Biotechniques 61 (1), 33-41, 2016 | 95 | 2016 |
| Disseminated tumor cells and dormancy in prostate cancer metastasis EE Van der Toom, JE Verdone, KJ Pienta Current opinion in biotechnology 40, 9-15, 2016 | 73 | 2016 |
| O-GlcNAcylation is required for mutant KRAS-induced lung tumorigenesis K Taparra, H Wang, R Malek, A Lafargue, MA Barbhuiya, X Wang, ... The Journal of clinical investigation 128 (11), 4924-4937, 2019 | 57 | 2019 |
| The prostate metastasis suppressor gene NDRG1 differentially regulates cell motility and invasion A Sharma, J Mendonca, J Ying, HS Kim, JE Verdone, JC Zarif, M Carducci, ... Molecular oncology 11 (6), 655-669, 2017 | 43 | 2017 |
| 3D shape modeling for cell nuclear morphological analysis and classification AA Kalinin, A Allyn-Feuer, A Ade, GV Fon, W Meixner, D Dilworth, ... Scientific reports 8 (1), 13658, 2018 | 35 | 2018 |
| Alternative CD44 splicing identifies epithelial prostate cancer cells from the mesenchymal counterparts JR Hernandez, JJ Kim, JE Verdone, X Liu, G Torga, KJ Pienta, ... Medical Oncology 32, 1-9, 2015 | 28 | 2015 |
| 3D cell nuclear morphology: microscopy imaging dataset and voxel-based morphometry classification results AA Kalinin, A Allyn-Feuer, A Ade, GV Fon, W Meixner, D Dilworth, ... Proceedings of the IEEE Conference on Computer Vision and Pattern …, 2018 | 25 | 2018 |
| Nucleolin staining may aid in the identification of circulating prostate cancer cells HJ Chalfin, JE Verdone, EE van der Toom, S Glavaris, MA Gorin, ... Clinical Genitourinary Cancer 15 (3), e477-e481, 2017 | 20 | 2017 |
| The presence of androgen receptor elements regulates ZEB1 expression in the absence of androgen receptor SM Mooney, P Parsana, JR Hernandez, X Liu, JE Verdone, G Torga, ... Journal of cellular biochemistry 116 (1), 115-123, 2015 | 20 | 2015 |
| Characterization of urothelial cancer circulating tumor cells with a novel selection-free method HJ Chalfin, M Kates, EE van der Toom, S Glavaris, JE Verdone, NM Hahn, ... Urology 115, 82-86, 2018 | 18 | 2018 |
| Epithelial–mesenchymal transition in prostate cancer is associated with quantifiable changes in nuclear structure JE Verdone, P Parsana, RW Veltri, KJ Pienta The Prostate 75 (2), 218-224, 2015 | 16 | 2015 |
| Aerobic glycolysis, motility, and cytoskeletal remodeling JE Verdone, JC Zarif, KJ Pienta Cell Cycle 14 (2), 169-170, 2015 | 11 | 2015 |
| A simple selection-free method for detecting disseminated tumor cells (DTCs) in murine bone marrow KC Valkenburg, SR Amend, JE Verdone, EE van der Toom, ... Oncotarget 7 (43), 69794, 2016 | 8 | 2016 |
| A surface tension magnetophoretic device for rare cell isolation and characterization EE van der Toom, JE Verdone, C Jun, D Petrisor, S Lim, JJ de La Rosette, ... Medical Oncology 34, 1-6, 2017 | 6 | 2017 |
| Chemotherapy increases aggressiveness of prostate cancer via epithelial mesenchymal transition JJ Kim, JE Verdone, SM Mooney Cell Biol: Res Ther 2 2, 2, 2013 | 4 | 2013 |
| Tobacco treatment in the setting of lung cancer screening JE Verdone, ET Marciniak, J Deepak Current Opinion in Pulmonary Medicine 30 (1), 3-8, 2024 | | 2024 |
